Initial Surgical Management of Medullary Thyroid Cancer
International Journal of Endocrine Oncology · 2016
DOI: 10.2217/ije-2015-0009 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrine Oncology, 2016. Verfasst von Kathryn E Coan und 1 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Medullary thyroid cancer (MTC) accounts for 5–10% of thyroid cancer. The majority, 75–80%, of MTC are sporadic with the remainder being hereditary secondary to a mutation in the RET proto-oncogene. Hereditary MTC may be isolated as in familial medullary thyroid cancer or associated with multiple endocrine neoplasia syndrome types 2A and 2B. The primary treatment modality for sporadic MTC is total thyroidectomy and central compartment neck dissection; consideration of lateral neck dissection should be based on preoperative imaging findings. The timing of prophylactic thyroidectomy is dependent on the specific RET codon mutation.
Zitieren
APA
Coan, K. E., & Wang, T. S. (2016). Initial Surgical Management of Medullary Thyroid Cancer. International Journal of Endocrine Oncology. https://doi.org/10.2217/ije-2015-0009
Vancouver
Coan KE, Wang TS. Initial Surgical Management of Medullary Thyroid Cancer. International Journal of Endocrine Oncology. 2016. doi:10.2217/ije-2015-0009
BibTeX
@article{Coan2016,
author = {Coan, Kathryn E and Wang, Tracy S},
title = {Initial Surgical Management of Medullary Thyroid Cancer},
journal = {International Journal of Endocrine Oncology},
year = {2016},
doi = {10.2217/ije-2015-0009}
}
EUVIMED